Kirill Nemirov
28 Rue Du Dr. Roux
Paris, 75015, France
Paris, 75015, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Eradication of pre-clinical prostate tumors by a lentiviral vector-based immunotherapy.
Journal: Molecular therapy. Oncology
Published: March 09, 2026
Lentiviral vector-based T-cell vaccines against Zika and yellow fever viruses.
Journal: Vaccine
Published: April 23, 2025
A lentiviral vector targeting a KRAS neoepitope for cancer immunotherapy.
Journal: Scientific reports
Published: March 17, 2025
Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses.
Journal: Frontiers in immunology
Published: April 18, 2023
Lentiviral Vectors as a Vaccine Platform against Infectious Diseases.
Journal: Pharmaceutics
Published: February 08, 2023
Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replication.
Journal: Microbes and infection
Published: December 29, 2022
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 13, 2022
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.
Journal: EMBO molecular medicine
Published: April 22, 2021
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.
Journal: Cell host & microbe
Published: September 08, 2020
Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1.
Journal: Cell reports
Published: August 02, 2013
Conserved proline-rich region of Ebola virus matrix protein VP40 is essential for plasma membrane targeting and virus-like particle release.
Journal: The Journal of infectious diseases
Published: October 12, 2011
Last Updated: 09/26/2026